StockNews.AI
STAA
StockNews.AI
18 hrs

Broadwood Partners Files Definitive Proxy Statement Soliciting STAAR Surgical Stockholders to Vote “AGAINST” Proposed Acquisition by Alcon

1. Broadwood Partners opposes STAAR's proposed acquisition, holding 27.5% of shares. 2. A proxy statement has been filed, indicating shareholder resistance.

M&A
+0.83%Current Return
VS
-0.32%S&P 500
$26.5509/24 08:20 AM EDTEvent Start
$26.7709/25 01:17 AM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bearish?

Resistance from a significant shareholder like Broadwood could indicate potential instability. Historical examples show such opposition often negatively impacts stock prices, especially during M&A discussions.

How important is it?

The significant stake of Broadwood indicates a large impact of their opposition on STAAR's shareholder dynamics.

Why Short Term?

The immediate proxy filing suggests potential volatility or decline until resolved, evident during recent M&A disputes.

Related Companies

ZTSMDTSYK
NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”), holders of approximately 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) today announced that it has filed a definitive proxy statement and GREEN proxy card with the U.S. Securities and Exchange Commission (the “SEC”) and sent a letter to its fellow stockholders in connection with its opposition to the proposed acquisition of the Company b.

Related News